Metraipolis › archive › dc_2af36eacdd3b

Immune checkpoint inhibitor-driven smooth muscle cell phenotypic modulation: a potential contributor to atherosclerotic risk associated with these therapies — Europe PMC PMID:42516948

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42516948
DOI
10.3389/fcvm.2026.1789821
License (as archived)
solo-consultazione
Archived
2026-10-18T07:47:18.969Z
SHA-256 of the archived text
b7f5bebe33c1bcf6277ecd29dab6c96781f7bfe5b8dea3ea31748f8c7a917899
Stable URL of this page
https://metraipolis.com/documento/dc_2af36eacdd3b

How to cite

Immune checkpoint inhibitor-driven smooth muscle cell phenotypic modulation: a potential contributor to atherosclerotic risk associated with these therapies — Europe PMC PMID:42516948 — Europe PMC (en), https://europepmc.org/article/MED/42516948 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2af36eacdd3b (Metraipolis archive dc_2af36eacdd3b, sha256 b7f5bebe33c1bcf6277ecd29dab6c96781f7bfe5b8dea3ea31748f8c7a917899)
BibTeX
@misc{dc2af36eacdd3b,
  title = {Immune checkpoint inhibitor-driven smooth muscle cell phenotypic modulation: a potential contributor to atherosclerotic risk associated with these therapies — Europe PMC PMID:42516948},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42516948},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2af36eacdd3b; sha256 b7f5bebe33c1bcf6277ecd29dab6c96781f7bfe5b8dea3ea31748f8c7a917899},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42516948. Agents can read the archived copy with the MCP tool read_document.